Whitehawk Therapeutics Inc (NASDAQ:WHWK) shares, rose in value on Wednesday, June 18, with the stock price up by 1.99% to the previous day’s close as strong demand from buyers drove the stock to $2.05.
Actively observing the price movement in the last trading, the stock closed the session at $2.01, falling within a range of $1.9219 and $2.11. The value of beta (5-year monthly) was 0.593 whereas the PE ratio was 13.67 over 12-month period. Referring to stock’s 52-week performance, its high was $3.81, and the low was $1.21. On the whole, WHWK has fluctuated by 16.48% over the past month.
With the market capitalization of Whitehawk Therapeutics Inc currently standing at about $96.57 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 33.33M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that WHWK’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 2.08, with the price of WHWK currently trading nearly 9.85% and 19.12% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.82, while the 7-day volatility ratio is showing 3.56% which for the 30-day chart, stands at 4.13%. Furthermore, Whitehawk Therapeutics Inc (WHWK)’s beta value is 0.51, and its average true range (ATR) is 0.14.
A comparison of Whitehawk Therapeutics Inc (WHWK) with its peers suggests the former has fared considerably weaker in the market. WHWK showed an intraday change of 1.99% in last session, and over the past year, it grew by 21.30%%.
Data on historical trading for Whitehawk Therapeutics Inc (NASDAQ:WHWK) indicates that the trading volumes over the past 10 days have averaged 0.11 and over the past 3 months, they’ve averaged 134.32K. According to company’s latest data on outstanding shares, there are 46.78 million shares outstanding.
Nearly 44.44% of Whitehawk Therapeutics Inc’s shares belong to company insiders and institutional investors own 45.75% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.17 million shares as on 2025-05-30, resulting in a short ratio of 0.88. According to the data, the short interest in Whitehawk Therapeutics Inc (WHWK) stood at 49.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.21 million. The stock has fallen by -35.02% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the WHWK stock heading into the next quarter.
